Prescribing drugs of dependence in general practice

Part C1 - Opioids

Figures and tables

Part C1 - Opioids
Download PDF

This clinical guideline was published in 2017, with minor updates in 2020.

The information provided may not reflect the most current evidence or best practice.

Guideline chapter figures and tables

Figures and tables from each chapter are available to view or download below.

Repatriation Pharmaceutical Benefits Scheme opioid utilisation in DDDs/1000 population/day

Figure 1.

Repatriation Pharmaceutical Benefits Scheme opioid utilisation in DDDs/1000 population/day
Download View full size
Repatriation Pharmaceutical Benefits Scheme opioid utilisation in DDDs/1000 population/day by drug

Figure 2.

Repatriation Pharmaceutical Benefits Scheme opioid utilisation in DDDs/1000 population/day by drug
Download View full size
Repatriation Pharmaceutical Benefits Scheme opioid utilisation in DDDs/1000 population/day by age group

Figure 3.

Repatriation Pharmaceutical Benefits Scheme opioid utilisation in DDDs/1000 population/day by age group
Download View full size
Rate of opioid* hospital separations for poisoning, per million persons, 2001 to 2011

Figure 4.

Rate of opioid* hospital separations for poisoning, per million persons, 2001 to 201112
Download View full size
Annual frequency of overdose deaths involving most frequent contributing individual drugs, Victoria 2009–16

Table 1.

Annual frequency of overdose deaths involving most frequent contributing individual drugs, Victoria 2009–1618
Download View full size
Opioid prescribing in Australia: Definitions of drug dependence, state and territory authority requirements* and prescription rules

Table 2

Opioid prescribing in Australia: Definitions of drug dependence, state and territory authority requirements* and prescription rules
Download View full size
Table 3.

Table 3.

Patient risk groups46
Download View full size
Patient groups that require caution when considering opioid therapy

Table 4.

Patient groups that require caution when considering opioid therapy53
Download View full size
Table 5.

Table 5.

State and territory legislative frameworks and clinical advisory services
Download View full size
Identifying patient risk

Table 6.

Identifying patient risk
Download View full size

Advertising